Hellings N - Search Results

1

Pathogenic features of CD4+CD28- T cells in immune disorders.

Broux B, Markovic-Plese S, Stinissen P, Hellings N. Broux B, et al. Among authors: hellings n. Trends Mol Med. 2012 Aug;18(8):446-53. doi: 10.1016/j.molmed.2012.06.003. Epub 2012 Jul 10. Trends Mol Med. 2012. PMID: 22784556 Review.

2

T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls.

Hellings N, Barée M, Verhoeven C, D'hooghe MB, Medaer R, Bernard CC, Raus J, Stinissen P. Hellings N, et al. J Neurosci Res. 2001 Feb 1;63(3):290-302. doi: 10.1002/1097-4547(20010201)63:3<290::AID-JNR1023>3.0.CO;2-4. J Neurosci Res. 2001. PMID: 11170179

3

Insights into the immunopathogenesis of multiple sclerosis.

Hellings N, Raus J, Stinissen P. Hellings N, et al. Immunol Res. 2002;25(1):27-51. doi: 10.1385/IR:25:1:27. Immunol Res. 2002. PMID: 11868933 Review.

4

Longitudinal study of antimyelin T-cell reactivity in relapsing-remitting multiple sclerosis: association with clinical and MRI activity.

Hellings N, Gelin G, Medaer R, Bruckers L, Palmers Y, Raus J, Stinissen P. Hellings N, et al. J Neuroimmunol. 2002 May;126(1-2):143-60. doi: 10.1016/s0165-5728(02)00052-8. J Neuroimmunol. 2002. PMID: 12020966

5

T cell vaccination in multiple sclerosis patients with autologous CSF-derived activated T cells: results from a pilot study.

Van der Aa A, Hellings N, Medaer R, Gelin G, Palmers Y, Raus J, Stinissen P. Van der Aa A, et al. Among authors: hellings n. Clin Exp Immunol. 2003 Jan;131(1):155-68. doi: 10.1046/j.1365-2249.2003.02019.x. Clin Exp Immunol. 2003. PMID: 12519400 Free PMC article.

6

Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controls.

Van der Aa A, Hellings N, Bernard CC, Raus J, Stinissen P. Van der Aa A, et al. Among authors: hellings n. J Neuroimmunol. 2003 Apr;137(1-2):164-76. doi: 10.1016/s0165-5728(03)00048-1. J Neuroimmunol. 2003. PMID: 12667661

7

Effects of prolactin on cloned human T-lymphocytes.

Dogusan Z, Martens N, Stinissen P, Hellings N, Demotte N, Hooghe R, Hooghe-Peters E. Dogusan Z, et al. Among authors: hellings n. Endocrine. 2003 Feb-Mar;20(1-2):171-6. doi: 10.1385/endo:20:1-2:171. Endocrine. 2003. PMID: 12668883

8

Characterization of three human oligodendroglial cell lines as a model to study oligodendrocyte injury: morphology and oligodendrocyte-specific gene expression.

Buntinx M, Vanderlocht J, Hellings N, Vandenabeele F, Lambrichts I, Raus J, Ameloot M, Stinissen P, Steels P. Buntinx M, et al. Among authors: hellings n. J Neurocytol. 2003 Jan;32(1):25-38. doi: 10.1023/a:1027324230923. J Neurocytol. 2003. PMID: 14618099

9

T-cell vaccination in multiple sclerosis: update on clinical application and mode of action.

Hellings N, Raus J, Stinissen P. Hellings N, et al. Autoimmun Rev. 2004 Jun;3(4):267-75. doi: 10.1016/j.autrev.2003.10.002. Autoimmun Rev. 2004. PMID: 15246022 Review.

10

Profiling the autoantibody repertoire by serological antigen selection.

Somers V, Govarts C, Hellings N, Hupperts R, Stinissen P. Somers V, et al. Among authors: hellings n. J Autoimmun. 2005 Nov;25(3):223-8. doi: 10.1016/j.jaut.2005.09.023. Epub 2005 Oct 26. J Autoimmun. 2005. PMID: 16256306

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters